Skip to main content
NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
1.130
-0.020 (-1.74%)
At close: Mar 9, 2026, 4:00 PM EDT
1.310
+0.180 (15.93%)
After-hours: Mar 9, 2026, 7:34 PM EDT

NEXGEL Revenue

NEXGEL had revenue of $2.93M in the quarter ending September 30, 2025, a decrease of -0.20%. This brings the company's revenue in the last twelve months to $11.67M, up 73.37% year-over-year. In the year 2024, NEXGEL had annual revenue of $8.69M with 112.47% growth.

Revenue (ttm)
$11.67M
Revenue Growth
+73.37%
P/S Ratio
0.79
Revenue / Employee
$614,000
Employees
19
Market Cap
9.20M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20248.69M4.60M112.47%
Dec 31, 20234.09M2.04M99.66%
Dec 31, 20222.05M497.00K32.04%
Dec 31, 20211.55M877.00K130.12%
Dec 31, 2020674.00K-43.00K-6.00%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Harvard Bioscience 87.37M
Retractable Technologies 37.90M
Bionano Genomics 28.72M
Precision Optics Corporation 24.42M
Jin Medical International 20.69M
Nephros 17.93M
Ekso Bionics Holdings 12.80M
Milestone Scientific 8.93M
Revenue Rankings

NXGL News

More News